Embolic Protection with Filtering or Occlusion Balloons during Saphenous Vein Graft Stenting Retrieves Identical Volumes and Sizes of Particulate Debris

Circulation

Volumn 109, Issue 14, 2004, Pages 1735-1740

  Rogers, Campbell ^a,c,f   Huynh, Rany ^b   Seifert, Philip A ^c   Chevalier, Bernard ^d   Schofer, Joachim ^e   Edelman, Elazer R ^a,c   Toegel, Gregory ^c   Kuchela, Arun ^a   Woupio, Amy ^b   Kuntz, Richard E ^a   Macon, Natalie D ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEDTRONIC INC   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^d Centre Cardiologique de Nord   (France)

^e Ctr Cardiol and Vasc Intervention   (Germany)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bypass; Embolism; Myocardial infarction; Stents

Indexed keywords

NITINOL;

ARTICLE; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; EMBOLISM; FILTER; HISTOPATHOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENT;

ALLOYS; BALLOON DILATATION; CALIBRATION; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; EMBOLISM; EQUIPMENT DESIGN; FILTRATION; FOAM CELLS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MICROSPHERES; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIALS; SAPHENOUS VEIN; STENTS; SUCTION; THROMBOSIS;

EID: 13844305659     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000124724.14491.6F     Document Type: Article

References (26)

1. Erbel R, Heusch G. Coronary microembolization: its role in acute coronary syndromes and interventions. Herz. 1999;24:558-575.
2. Plana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation. 1994; 89:2514-2518.
3. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 2001;37: 2215-2239.
4. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts. Circulation. 2002;106:3063-3067.
5. Ellis SG, Lincoff AM, Miller D, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol. 1998;32:1619-1623.
6. Mathew V, Grill DE, Scott CG, et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol. 1999;34:1163-1169.
7. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet GP IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts. Circulation. 2002; 106:3063-3067.
8. Webb J, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol. 1999; 34:468-475.
9. Oesterle SN, Hayase M, Baim DS, et al. An embolization containment device. Cathet Cardiovasc Intervent. 1999;47:243-250.
10. Carlino M, Di Gregorio J, Di Mario C, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Circulation. 1999;99:3221-3223.
11. Henry M, Amor M, Henry I, et al. Carotid stenting with cerebral protection: first clinical experience using the PercuSurge GuardWire system. J Endovasc Surg. 1999;6:321-331.
12. Muller R, Gerckens U, Staberock M, et al. Clinical experiences with the PercuSurge GuardWire: a new system for prevention of peripheral embolisms in catheter interventions on degenerated coronary artery venous bypasses [in German]. Z Kardiol. 2000;89:316-322.
13. Ohki T, Roubin GS, Veith FJ, et al. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: an ex vivo analysis. J Vasc Surg. 1999;30:1034-1044.
14. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-580.
15. Al-Mubarek N, Columbo A, Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol. 2002;38:841-846.
16. Schluter M, Chevalier B, Seth A, et al. Saphenous vein graft stenting using a novel filter device for distal protection. Am J Cardiol. 2003;91: 736-739.
17. Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation. 2001;104:12-15.
18. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-1290.
19. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-553.
20. Grube E, Schofer J, Webb J, et al. for the Saphenous Vein Graft Angioplasty Free of Emboli (SAFE) Trial Study Group. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol. 2002;89:941-945.
21. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary artery bypass grafts: ten years later. Am J Cardiol. 1984;53:102C-107C.
22. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. Circulation. 1995;91:1966-1974.
23. Bhargava B, Kornowski R, Mehran R, et al. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol. 2000;35:389-397.
24. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100:2400-2405.
25. Resnic FS, Wainstein M, Lee MKY, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003;145;42-46.
26. Qureshi AI, Luft AR, Janardhan V, et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke. 2000;31:376-382.